MAPT and Alzheimer disease: Most animal studies focus on the behavioral and biological effects of DBS in AD models, including acetylcholine (ACh) release, nerve growth factor (NGF) synthesis induction, and reductions in amyloid-beta (Aβ) and tau protein levels [40,45,46].